Pfizer Inc (PFE)

$25.33 0.00 (N/A)
Market Cap 144.37B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.41
Forward PE 8.62
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 34,111,200
Avg Vol 37,779,813
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 9%
Beta 0.35
Analysts Sell
Price Target $29.24

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
AirForce1000
AirForce1000 May. 19 at 2:37 AM
$PFE https://www.knicksnewyork.com🏀
0 · Reply
datavirtue
datavirtue May. 19 at 2:15 AM
$PFE I smell a divvy cut coming...this might be a slog. Big money is not labelling this as safe right now.
3 · Reply
BillionerOfKing
BillionerOfKing May. 19 at 1:56 AM
$PFE Current Stock Price: $25.33 Contracts to trade: $25.5 PFE May 22 2026 Call Entry: $0.18 Exit: $0.31 ROI: 73% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Ataifanboymentalhealthz
Ataifanboymentalhealthz May. 19 at 1:50 AM
$KAPA my guess $JNJ because ERLEADA (apalutamide) works but suffers resistance. Kairos is testing ENV105 with it and ZYTIGA. But could also be $PFE with XTANDI. Those would be my guesses
0 · Reply
A_Train1
A_Train1 May. 19 at 1:41 AM
$PFE why oh why did I buy this stock? Nothing but disappointment day after day
1 · Reply
Zero12345
Zero12345 May. 19 at 1:16 AM
$NVAX $PFE While Shah Capital has invested in multiple global sectors-including solar, telecom, and pharmaceuticals-their most notable public activist campaign has involved Novavax (NVAX) Novavax Campaign: Shah Capital is a ~9% shareholder and has been one of the vaccine maker's most vocal critics. Himanshu Shah has heavily pressured the company to cut executive compensation, downsize its board of directors, and even pursue a potential sale of the company to maximize shareholder value. Ongoing Pressure: Shah Capital continued to escalate its push against Novavax's leadership, sending presentation decks to the board sharply criticizing the company's financial performance, capital market decisions, and marketing strategies. (Pfizer and Novavax entered a $530 million licensing agreement that grants Pfizer non- exclusive, worldwide access to Novavax's Matrix- M adjuvant technology.) ⏬️ Himanshu H. Shah ⏬️ Founder & Executive Chairman, Shah Capital & Marius Pharmaceuticals
0 · Reply
Wallst45
Wallst45 May. 19 at 12:25 AM
$PFE CEO BOURLA will be fired soon
2 · Reply
Wallst45
Wallst45 May. 19 at 12:24 AM
$PFE dumb stock
1 · Reply
WSTB20
WSTB20 May. 18 at 11:32 PM
$PFE
0 · Reply
CapitalMonk
CapitalMonk May. 18 at 10:31 PM
$PFE Price: $25.33 (+0.00%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.77% RSI: 36.1 | Momentum: Moderate Volume: -11.7% vs avg Volatility: 0.95% Support: $25.19 | Resistance: $27.17 Sourch: http://marketbaubles.com/
0 · Reply
Latest News on PFE
PFE, NVO, LLY: Pharma Stocks Drop as TrumpRx Set for ‘Dramatic Expansion’

2026-05-18T17:01:06.000Z - 11 hours ago

PFE, NVO, LLY: Pharma Stocks Drop as TrumpRx Set for ‘Dramatic Expansion’

AZN LLY NVO SNY

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 18, 2026, 8:00 AM EDT - 16 hours ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

May 14, 2026, 2:22 PM EDT - 4 days ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

Pfizer price target raised to $26 from $25 at Wolfe Research

2026-05-14T17:29:38.000Z - 4 days ago

Pfizer price target raised to $26 from $25 at Wolfe Research

Mixed options sentiment in Pfizer with shares up 0.48%

2026-05-13T19:23:39.000Z - 5 days ago

Mixed options sentiment in Pfizer with shares up 0.48%

Arvinas price target raised to $16 from $14 at BofA

2026-05-13T19:22:15.000Z - 5 days ago

Arvinas price target raised to $16 from $14 at BofA

ARVN RIGL

Pfizer says EC grants marketing approval to expand indication for Hympavzi

2026-05-13T11:10:14.000Z - 5 days ago

Pfizer says EC grants marketing approval to expand indication for Hympavzi

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 13, 2026, 6:45 AM EDT - 5 days ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

2026-05-13T07:12:25.000Z - 5 days ago

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

LLY NVO

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

2026-05-12T17:45:03.000Z - 6 days ago

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

ARVN RIGL

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

2026-05-12T16:35:26.000Z - 6 days ago

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

ARVN RIGL

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

2026-05-12T13:02:04.000Z - 6 days ago

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

ARVN RIGL

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

May 12, 2026, 8:00 AM EDT - 6 days ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

May 12, 2026, 7:00 AM EDT - 6 days ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

Mixed options sentiment in Pfizer with shares down 1.52%

2026-05-08T22:49:53.000Z - 10 days ago

Mixed options sentiment in Pfizer with shares down 1.52%

Mixed options sentiment in Pfizer with shares up 0.28%

2026-05-07T01:58:20.000Z - 12 days ago

Mixed options sentiment in Pfizer with shares up 0.28%

Pfizer sees high-single-digit annual revenue increases 2029-2033, WSJ reports

2026-05-05T20:09:06.000Z - 13 days ago

Pfizer sees high-single-digit annual revenue increases 2029-2033, WSJ reports

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 13 days ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 13 days ago

Pfizer CEO on AI-designed molecule, and race to use new tech

3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 13 days ago

3 Dividend Stocks for May 2026

SYY WSO

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 13 days ago

Pfizer Earnings Call Transcript: Q1 2026

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 13 days ago

Pfizer Posts Better-Than-Expected Revenue, Profit

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 13 days ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:06 AM EDT - 13 days ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 13 days ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:55 AM EDT - 13 days ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:51 AM EDT - 13 days ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 5, 2026, 6:45 AM EDT - 13 days ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 17 days ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 19 days ago

Pfizer's blood cancer drug meets main goal in late-stage trial

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 29, 2026, 6:45 AM EDT - 19 days ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:41 AM EDT - 20 days ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 20 days ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Apr 24, 2026, 8:36 AM EDT - 24 days ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 25 days ago

Pfizer Transcript: AGM 2026

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 26 days ago

Pfizer Declares Second-Quarter 2026 Dividend

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 26 days ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 21, 2026, 11:51 AM EDT - 27 days ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 3:05 PM EDT - 4 weeks ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 20, 2026, 6:45 AM EDT - 4 weeks ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 4 weeks ago

The Big 3: PFE, V, SYF

SYF V

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 5 weeks ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 9, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Apr 2, 2026, 11:14 AM EDT - 6 weeks ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 6 weeks ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Apr 1, 2026, 10:13 AM EDT - 6 weeks ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 7 weeks ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 2 months ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 2 months ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 2 months ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 2 months ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 2 months ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 2 months ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 2 months ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 2 months ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 2 months ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 2 months ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 2 months ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 2 months ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 2 months ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 2 months ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 2 months ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

AirForce1000
AirForce1000 May. 19 at 2:37 AM
$PFE https://www.knicksnewyork.com🏀
0 · Reply
datavirtue
datavirtue May. 19 at 2:15 AM
$PFE I smell a divvy cut coming...this might be a slog. Big money is not labelling this as safe right now.
3 · Reply
BillionerOfKing
BillionerOfKing May. 19 at 1:56 AM
$PFE Current Stock Price: $25.33 Contracts to trade: $25.5 PFE May 22 2026 Call Entry: $0.18 Exit: $0.31 ROI: 73% Hold ~26 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Ataifanboymentalhealthz
Ataifanboymentalhealthz May. 19 at 1:50 AM
$KAPA my guess $JNJ because ERLEADA (apalutamide) works but suffers resistance. Kairos is testing ENV105 with it and ZYTIGA. But could also be $PFE with XTANDI. Those would be my guesses
0 · Reply
A_Train1
A_Train1 May. 19 at 1:41 AM
$PFE why oh why did I buy this stock? Nothing but disappointment day after day
1 · Reply
Zero12345
Zero12345 May. 19 at 1:16 AM
$NVAX $PFE While Shah Capital has invested in multiple global sectors-including solar, telecom, and pharmaceuticals-their most notable public activist campaign has involved Novavax (NVAX) Novavax Campaign: Shah Capital is a ~9% shareholder and has been one of the vaccine maker's most vocal critics. Himanshu Shah has heavily pressured the company to cut executive compensation, downsize its board of directors, and even pursue a potential sale of the company to maximize shareholder value. Ongoing Pressure: Shah Capital continued to escalate its push against Novavax's leadership, sending presentation decks to the board sharply criticizing the company's financial performance, capital market decisions, and marketing strategies. (Pfizer and Novavax entered a $530 million licensing agreement that grants Pfizer non- exclusive, worldwide access to Novavax's Matrix- M adjuvant technology.) ⏬️ Himanshu H. Shah ⏬️ Founder & Executive Chairman, Shah Capital & Marius Pharmaceuticals
0 · Reply
Wallst45
Wallst45 May. 19 at 12:25 AM
$PFE CEO BOURLA will be fired soon
2 · Reply
Wallst45
Wallst45 May. 19 at 12:24 AM
$PFE dumb stock
1 · Reply
WSTB20
WSTB20 May. 18 at 11:32 PM
$PFE
0 · Reply
CapitalMonk
CapitalMonk May. 18 at 10:31 PM
$PFE Price: $25.33 (+0.00%) Trend: Bullish Market Bias (7D): Sideways ⚖️ Expected Range: ±0.77% RSI: 36.1 | Momentum: Moderate Volume: -11.7% vs avg Volatility: 0.95% Support: $25.19 | Resistance: $27.17 Sourch: http://marketbaubles.com/
0 · Reply
saikris007
saikris007 May. 18 at 10:01 PM
$PFE after hours already 5M traded
2 · Reply
JBS_84
JBS_84 May. 18 at 9:04 PM
$PFE Bottom has to be close. Either here, 24.85 or somewhere in-between thereabouts. Has to at least sustain above the 20hourly and get a crossover. The head and shoulders on the daily is about played out I think.
2 · Reply
JBS_84
JBS_84 May. 18 at 8:59 PM
$PFE why so everyone can say they are evil again? Injecting microchips etc.
1 · Reply
Merica90
Merica90 May. 18 at 7:43 PM
$PFE accumulating slowly.
1 · Reply
SilverTrader47
SilverTrader47 May. 18 at 7:18 PM
$PFE has the capability to design an mRNA vaccine for Ebola just like it did for COVID-19. mRNA technology acts like a biological software platform. If you change the genetic code "instructions" from the COVID spike protein to the Ebola surface glycoprotein, the body can learn to fight Ebola. US CDC says one American tested positive for Ebola https://www.reuters.com/business/healthcare-pharmaceuticals/us-cdc-says-one-american-tested-positive-ebola-2026-05-18/
0 · Reply
Willieberich
Willieberich May. 18 at 7:18 PM
$PFE bought!
0 · Reply
pasuny
pasuny May. 18 at 7:02 PM
$PFE The worst CEO in human history! Fire him!!!!!!!!!
1 · Reply
Micheal_Pothead
Micheal_Pothead May. 18 at 7:02 PM
$PFE worthless
0 · Reply
pasuny
pasuny May. 18 at 6:51 PM
$PFE Pathetic miserable worthless piece of sxxt.
0 · Reply
pasuny
pasuny May. 18 at 6:40 PM
$PFE stupid fuckin filthy disgusting garbage
0 · Reply
JBS_84
JBS_84 May. 18 at 6:39 PM
$PFE The hourly is suggesting 25.
1 · Reply
55X_ROI_Q1_2026
55X_ROI_Q1_2026 May. 18 at 5:57 PM
$SLS -- Is it $PFE $ABBV or $MRK
1 · Reply